Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New EU Regulations: What Could Possibly Go Wrong?

Executive Summary

How much faith do medtech regulatory experts have in the forthcoming medical device and IVD regulations and will they be ready on time? While the EU is making significant progress, experts continue to have serious concerns about implementation of the new regulations and the impact on industry.

You may also be interested in...



Notified Body Numbers Continue To Fall

The number of notified bodies in the EU medtech arena continues to drop, as predicted, as the tougher new requirements for these organizations take hold. Here's a look at the country-by-country details.

EU’s Eudamed Database: Crucial To New Regs, But Will It Be Ready in Time?

The EU must have its new Eudamed database operating smoothly to support the implementation of the new IVD and Medical Device Regulations. But experience with its predecessor suggests progress may not always be straightforward.

Transition Arrangements For IVDs Under New EU Regulation: How Much Longer Is CE Marking Valid?

Transitioning to the new EU IVD Regulation is going to require a major overhaul of processes and technical documents for IVD companies and also place heavy demands on EU notified bodies. So how long do those operating in the EU have to comply? And what is required in terms of governance? Some answers below.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT104129

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel